threonine has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SA; Cha, SI; Choi, JE; Choi, SH; Do Yoo, J; Do, SK; Hong, MJ; Kang, HG; Kim, CH; Kim, JH; Kim, S; Lee, J; Lee, JH; Lee, SY; Lee, WK; Lee, YH; Park, JY; Seo, H; Yoo, SS | 1 |
| Cao, G; Feng, J; Hou, Y; Lu, H; Shu, J; Zheng, D | 1 |
2 other study(ies) available for threonine and Carcinoma, Small Cell
| Article | Year |
|---|---|
Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome.
Topics: Aged; Alanine; Amino Acid Substitution; Antigens, Differentiation, T-Lymphocyte; Carcinoma, Small Cell; Female; Glycine; Humans; Lung Neoplasms; Male; Polymorphism, Genetic; Receptors, Virus; Serine; Threonine; Treatment Outcome | 2021 |
Lung cancer risk associated with Thr495Pro polymorphism of GHR in Chinese population.
Topics: Adenocarcinoma; Aged; Asian People; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Female; Genotype; Humans; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Proline; Receptors, Somatotropin; Risk Assessment; Risk Factors; Smoking; Threonine | 2008 |